What are the causes of non‑cirrhotic portal hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Non-Cirrhotic Portal Hypertension

Non-cirrhotic portal hypertension results from vascular disorders in the portal system, granulomatous diseases, thrombophilic conditions, infections, medications, and genetic hepatobiliary disorders—all causing elevated portal pressure without cirrhotic architectural distortion. 1

Anatomical Classification Framework

The causes are best understood by anatomical location of the vascular resistance:

Prehepatic Causes

  • Portal vein thrombosis is the most common prehepatic cause, often associated with underlying thrombophilia 1
  • Splenic vein thrombosis creates isolated left-sided portal hypertension 1

Intrahepatic (Non-Cirrhotic) Causes

Vascular Disorders

  • Idiopathic non-cirrhotic portal hypertension (INCPH) represents obliterative portal venopathy with three characteristic histological lesions: portal venopathy, nodular regenerative hyperplasia, and incomplete septal fibrosis 2
  • Non-cirrhotic portal fibrosis (NCPF) is characterized by phlebosclerosis (obliterative portal venopathy), perisinusoidal fibrosis, and para-portal shunt vessels while maintaining lobular architecture 2
  • Nodular regenerative hyperplasia can cause portal hypertension even in precirrhotic stages 1

Infectious Causes

  • Schistosomiasis causes presinusoidal portal hypertension through granuloma formation with periportal fibrosis, particularly common in endemic regions 1, 3
  • Chronic abdominal infections are the most important etiological factor in Eastern patients 4

Genetic/Metabolic Disorders

  • Congenital hepatic fibrosis affects the hepatobiliary system through genetic alterations 1
  • Sarcoidosis causes granulomatous infiltration leading to portal hypertension 1

Medication and Toxin Exposure

  • Specific medications and toxic plant exposure can cause sinusoidal obstruction syndrome (veno-occlusive disease) 3

Posthepatic Causes

  • Budd-Chiari syndrome results from thrombosis of hepatic veins or inferior vena cava 1
  • Sinusoidal obstruction syndrome (veno-occlusive disease) obstructs hepatic venous outflow 1, 3
  • Right heart failure causes backward transmission of elevated venous pressure 1

Etiological Categories for INCPH

When evaluating idiopathic non-cirrhotic portal hypertension specifically, screen for five categories:

  • Thrombophilic disorders are identified in approximately 40% of Western patients and represent the most important factor in this population 2, 4
    • Screen for inherited thrombophilias, myeloproliferative neoplasms, and antiphospholipid syndrome 2
  • Immunological disorders including autoimmune conditions 4
  • Chronic infections, particularly HIV 1, 4
  • Medication or toxin exposure 4
  • Genetic disorders affecting hepatobiliary function 4

Critical Diagnostic Pitfall

Patients with non-cirrhotic portal hypertension are frequently misclassified as cirrhotic on ultrasound due to liver surface nodularity and portal vein wall thickening. 2 A key distinguishing feature is transient elastography showing low liver stiffness (<12 kPa) despite signs of portal hypertension, which should prompt consideration of NCPH rather than cirrhosis 2. Liver biopsy that definitively excludes cirrhosis and advanced fibrosis remains essential for diagnosis 2, 1.

Hemodynamic Distinction

In prehepatic and presinusoidal causes, the hepatic venous pressure gradient (HVPG) remains normal because wedged pressure does not reflect portal pressure; therefore, measurement of intravariceal or intrasplenic pressure is needed to assess portal pressure accurately 1, 5.

References

Guideline

Causes of Portal Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Non‑Cirrhotic Portal Fibrosis (NCPF): Evidence‑Based Diagnostic and Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Non-cirrhotic portal hypertension--concept, diagnosis and clinical management.

Clinics and research in hepatology and gastroenterology, 2014

Research

Idiopathic noncirrhotic portal hypertension.

Hepatology (Baltimore, Md.), 2011

Research

Non-cirrhotic portal fibrosis: current concepts and management.

Journal of gastroenterology and hepatology, 2002

Related Questions

What are the causes of non-cirrhotic portal fibrosis?
What are the causes of non-cirrhotic portal hypertension (NCPH)?
What is the management of Non-Cirrhotic Portal Fibrosis (NCPF)?
How are non-cirrhotic causes of portal hypertension managed?
What is the treatment for non-cirrhotic portal fibrosis (NCPF)?
In a 2‑month‑old exclusively breastfed boy with several episodes of watery, mucus‑laden diarrhea, stool leukocytes (8‑10 per high‑power field) and positive mucus, who has been hospitalized for four days with respiratory distress but no clear radiographic evidence of pneumonia, what is the appropriate inpatient management regarding fluid resuscitation, antimicrobial therapy, and respiratory support?
What are the current guideline-recommended treatments for severe hypercalcemia of malignancy in a 77-year-old woman with spindle-cell cancer, ionized calcium 1.6 mmol/L and impaired renal function (serum creatinine 3.7 mg/dL)?
What are the considerations and recommended management for a prenatal ultrasound showing bilateral duplicated collecting systems with single ureters and mild ureteropelvic caliectasis (right 0.6 cm, left 0.9 cm)?
In a 27‑year‑old female with a one‑day history of fever (up to 38.9 °C) and sore throat with erythematous inflamed pharynx but no tonsillar swelling or exudates, plus myalgia and low‑back pain, what is the most likely diagnosis and what are the appropriate next steps in management?
How should an asymptomatic adult with a TI‑RADS 3 thyroid nodule on neck ultrasound and no high‑risk clinical features be managed?
Why should succinylcholine be avoided in patients with acute traumatic brain injury?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.